All APAC articles

Finance

David Gill Chairs Telix Pharma Board of Directors

David Gill Chairs Telix Pharma Board of Directors

David Gill has been appointed as Chair of the Board at Telix Pharmaceuticals Limited. He brings extensive board and executive leadership experience across the biopharmaceutical, medical technology and healthcare sectors. His appointment follows a career spanning senior financial and operational roles, company leadership and board positions across healthcare businesses.

Gill currently serves as Chairperson of the Board at Telix Pharmaceuticals, alongside board appointments at Keystone Dental Group, Bioretec and Allucent. His previous board roles include Evolus, Y-mAbs Therapeutics, HealthTronics, Melinta Therapeutics and Histogenics. He has also held senior executive positions including President, COO and CFO at EndoChoice, SVP and CFO at NxStage Medical, and President at Dornier MedTech. Earlier in his career, he held finance and leadership roles at CTI Molecular Imaging, Novoste Corporation and Price Waterhouse Coopers.

Topics

  • board
  • gill
  • telix
  • david
  • leadership
  • roles
  • career
  • cfo
  • chairs
  • directors
  • executive
  • healthcare

Share this article

Send it to a colleague or post it to your network.

Similar posts